These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
7. Latamoxef (moxalactam) kinetics in volunteers studied by a specific HPLC assay technique. Shepherd AM; Hardin TC; Ludden TM; Miner DJ; Coleman DL J Antimicrob Chemother; 1983 Oct; 12(4):377-86. PubMed ID: 6643333 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of moxalactam in anuric children and during hemodialysis. Kaplan SL; Berry PL; Mason EO; Kramer WG Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Aronoff GR; Sloan RS; Luft FC J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824 [TBL] [Abstract][Full Text] [Related]
11. [Comparative pharmacokinetics of moxalactam and other cephalosporins]. Fourtillan JB; Brisson AM Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of ceftazidime and moxalactam. Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L Antimicrob Agents Chemother; 1982 Aug; 22(2):237-41. PubMed ID: 6765416 [TBL] [Abstract][Full Text] [Related]
14. Activity, stability, and pharmacology of the epimers of moxalactam. Wise R; Wright N; Wills PJ Rev Infect Dis; 1982; 4 Suppl():S564-8. PubMed ID: 6218567 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dexrazoxane in subjects with impaired kidney function. Brier ME; Gaylor SK; McGovren JP; Glue P; Fang A; Aronoff GR J Clin Pharmacol; 2011 May; 51(5):731-8. PubMed ID: 20484616 [TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate. Chládková J; Hak J; Martínková J; Chládek J Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of single-dose administration of moxalactam in unweaned calves. Soback S Am J Vet Res; 1989 Apr; 50(4):498-501. PubMed ID: 2653122 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime. Wise R; Andrews JM Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427 [TBL] [Abstract][Full Text] [Related]
19. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563 [TBL] [Abstract][Full Text] [Related]
20. On the pharmacokinetics of latamoxef in normal and impaired renal function. Höffler D; Koeppe P; Moecke D Arzneimittelforschung; 1984; 34(3):317-20. PubMed ID: 6539614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]